Á lódáil...
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
PURPOSE: Oral mucositis is a significant toxicity of cytotoxic chemo- and radiation-therapy used to treat cancer. Palifermin is the first pharmaceutical/biological agent approved for the intervention of oral mucositis. The major objective of this review is to evaluate the evidence supporting the use...
Na minha lista:
Príomhúdar: | |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Dove Medical Press
2010
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899789/ https://ncbi.nlm.nih.gov/pubmed/20694076 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|